TGA Approval

ACTAVANZ lisdexamfetamine dimesilate 60 mg capsules bottle (406913)

ARTG ID

406913

ARTG Name

ACTAVANZ lisdexamfetamine dimesilate 60 mg capsules bottle

Sponsor

Actor Pharmaceuticals Pty Ltd

ARTG Date

January 22, 2024

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Actor Pharmaceuticals Pty Ltd

Ingredient Name

lisdexamfetamine dimesilate

Empowering clinical research with data-driven insights and AI-powered tools.

ACTAVANZ lisdexamfetamine dimesilate 60 mg capsules bottle (406913) - TGA 批准文号 | MedPath